Literature DB >> 19454444

Hematopoietic growth factors: ESMO recommendations for the applications.

J Crawford1, C Caserta, F Roila.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19454444     DOI： 10.1093/annonc/mdp162

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

Authors:  Mélanie L Pastor; Céline M Laffont; Laurence Gladieff; Antonin Schmitt; Etienne Chatelut; Didier Concordet
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

2.  Model-based approach to early predict prolonged high grade neutropenia in carboplatin-treated patients and guide G-CSF prophylactic treatment.

Authors:  Mélanie L Pastor; Céline M Laffont; Laurence Gladieff; Etienne Chatelut; Didier Concordet
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

3.  A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

Authors:  S Barni; V Lorusso; M Giordano; G Sogno; T Gamucci; A Santoro; R Passalacqua; V Iaffaioli; N Zilembo; M Mencoboni; M Roselli; G Pappagallo; P Pronzato
Journal:  Med Oncol       Date:  2013-12-05       Impact factor: 3.064

4.  Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Authors:  J E Cox; S Campos; J Wu; R May; H Liu; C A Ramos; G Carrum; H E Heslop; M K Brenner; R T Kamble
Journal:  Bone Marrow Transplant       Date:  2013-10-07       Impact factor: 5.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.